Viewing Study NCT01672450


Ignite Creation Date: 2025-12-24 @ 5:10 PM
Ignite Modification Date: 2026-02-25 @ 4:11 AM
Study NCT ID: NCT01672450
Status: COMPLETED
Last Update Posted: 2015-07-08
First Post: 2012-08-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma
Sponsor: University of Utah
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Histologically or cytologically proven melanoma; Stages III-IV; accessible cutaneous, subcutaneous, … View